U.S. Cuts Funding for Disease Outbreak Research Network

The Trump administration has stopped funding a research network designed to detect and study diseases before they spread widely. The network, called CREID (Centers for Research in Emerging Infectious Diseases), was built to help scientists catch new and dangerous infections early — especially in parts of the world where outbreaks happen most often.

The National Institutes of Health confirmed the funding is ending. The program had cost about $17 million per year at its start and involved multiple research centers around the globe working to spot emerging health threats.

What the Network Did

Scientists in the CREID network worked on two main things: building tools to quickly identify new diseases, and studying how human bodies respond when exposed to unfamiliar infections. The network was coordinated from North Carolina and included centers in multiple countries, with a focus on regions where diseases emerge frequently.

One example was a center based in West Africa that studied infectious disease risks in that region. The idea was to have experts from many fields — biologists, engineers, and others — working together across borders to catch problems early.

How This Differs from Other Disease Programs

The U.S. government runs a separate disease monitoring program called the Emerging Infections Program (EIP) through the Centers for Disease Control. That program has 12 locations across the U.S. and focuses on tracking diseases domestically and helping shape public health policy. CREID was different — it operated internationally and specialized in rapidly developing ways to detect diseases in places with limited laboratory resources.

Both programs tackled emerging disease threats, but with different scopes and methods.

Why This Matters

Cutting CREID funding removes a specialized capability. The network's main strength was being able to develop detection tools quickly for novel pathogens in regions where diagnostic labs may be sparse or unavailable. During the COVID-19 pandemic, the speed of detecting and identifying the virus became crucial; CREID was partly designed to address weaknesses exposed by that experience.

The network also trained and funded graduate students and early-career researchers focused on emerging diseases. Those researchers will lose that support. Beyond the direct impact, international partnerships that took years to build will lose the funding that kept them coordinated and resourced. While researchers may maintain informal connections, the infrastructure that enabled rapid collaboration disappears.

The broader context here involves how the new administration is reshaping federal research priorities. At the same time CREID funding ended, other areas — like artificial intelligence and semiconductor research — received increased support, reflecting different judgments about which scientific work matters most to national security.

Worth flagging: ending this program during a period when new disease threats remain a genuine global risk raises a real tension. The specialized expertise and relationships CREID had developed take years to rebuild. Once a new outbreak emerges, that capability cannot be quickly restored. The research community will have to look for support elsewhere — through private foundations or state programs — to try to maintain this work, but the federal infrastructure is now gone.